AlvotechAlvotechAlvotech

Alvotech

No trades
See on Supercharts
Market capitalization
‪3.68 B‬USD
−2.33USD
‪−551.73 M‬USD
‪91.43 M‬USD
‪109.14 M‬
Beta (1Y)
0.28

About Alvotech


CEO
Joel Morales
Headquarters
Luxembourg
Founded
2013
ISIN
LU2458333858
FIGI
BBG0186DQF77
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Displays a symbol's price movements over previous years to identify recurring trends.